tirzepatide vs semaglutide weight loss trials Comparing for in Adults with Obesity: JAMA Study BodyByBariatrics

These are the findings of a new study funded by Eli Lilly, which makes both Trulicity and Mounjaro

Tirzepatide (Mounjaro, Zepbound) Tirzepatide is a dualacting medication that targets both GLP1 and glucosedependent insulinotropic polypeptide (GIP) receptors, which may enhance its effects on appetite regulation and metabolism

Slow Gastric Emptying By slowing the rate at which the stomach empties after meals, semaglutide increases feelings of fullness for longer periods, helping control portion sizes and reduce snacking

Aim to consume most of your daily water between morning and mid-afternoon

Boehringers high-concentration formulation of adalimumab-adbm was approved by the FDA in May 2024, whereas the low-concentration formulation has been commercially available since July 2023